Skip to main content
. Author manuscript; available in PMC: 2018 Jul 16.
Published in final edited form as: Ann Intern Med. 2017 Dec 5;168(2):100–109. doi: 10.7326/M17-1319

Table 2.

Diagnostic Variants Identified in Exome Sequencing

Patient
Identification
Sex Age,
y
Race/E
thnicit
y
Clinical
Presentation
Genetic Diagnosis Gene
Symbol
Sequence Variant,
RSID, and ExAC
Frequency
Clinical Implications
of Genetic
Information
Genetic diagnoses that confirmed the clinical diagnosis and their potential implications on clinical care

K008 Female 28 White ESRD of unknown cause, has undergone kidney transplantation, son has Alport syndrome X-linked Alport syndrome (OMIM 301050) COL4A5 NM_000495:c.G3310T:p.G1104C Clarification of mode of inheritance; screening family members
RSID: NA
ExAC frequency: 0

K009 Male 26 White Biopsy-proven Alport syndrome, negative FHx X-linked Alport syndrome (OMIM 301050) COL4A5 NM_000495:c.G2731A:p.G911R Clarification of mode of inheritance; screening family members
RSID: rs281874704
ExAC frequency: 0

K024 Female 31 White Biopsy-proven Alport syndrome, negative FHx X-linked Alport syndrome (OMIM 301050) COL4A5 NM_000495:c.G5042A:p.C1681Y Clarification of mode of inheritance; screening family members
RSID: NA
ExAC frequency: 0

K079 Male 22 White Biopsy-proven Alport syndrome, positive FHx X-linked Alport syndrome (OMIM 301050) COL4A5 NM_000495:c.G2474A:p.G825E Clarification of mode of inheritance; screening family members
RSID: NA
ExAC frequency: 0

K054 Female 31 White Nail–patella syndrome with biopsy-proven FSGS Nail–patella syndrome (OMIM 161200) LMX1B NM_001174146: 775_776del: p.S259Cfs*38 Do not consider immunosuppression; refer for transplant
RSID: NA
ExAC frequency: 0

K015 Male 37 Asian Fabry disease by biopsy and enzyme activity, ESRD Fabry disease(OMIM 301500) GLA NM_000169:c.A886G:p.M296V Screening family members; continue enzyme therapy
RSID: rs104894830
ExAC frequency: 4 × 10−6
Genetic diagnoses that provided new information and their potential implications on clinical care

K030 Male 19 African American CKD of unknown cause with bilateral renal hypoplasia, hypogonadism; history of repaired atrial septal defect; offspring of healthy parents CHARGE syndrome (OMIM 214800) CHD7 NM_017780:c.G8554A:p.D2852N Screening for hearing and visual loss, cranial nerve dysfunction, and learning disability; caution during anesthesia because of upper airway maldevelopment
RSID: NA
ExAC frequency: 0

KGY1 Male 35 White Familial proteinuric CKD of unknown cause, inconclusive results on biopsies at age 6 and 12 y, brother with proteinuria (never had biopsy) Dent disease 1 (OMIM 300009) CLCN5 NM_000084:c.2057delG:p.S686Tfs*5 Therapy with thiazide diuretics and citrates; no posttransplant recurrence expected; brother screened and diagnosed with Dent disease 1
RSID: NA
ExAC frequency: 0

K014 Female 22 White ESRD of unknown cause, has undergone kidney transplantation, positive FHx of microhematuria on father’s side Autosomal recessive Alport syndrome (OMIM 203780) COL4A3 NM_000091:c.G1558C:p.G520R
  • RSID: NA

  • ExAC frequency: 0

Posttransplant recurrence unlikely; compound heterozygosity confirmed by testing allele transmission in offspring; immunosuppressive therapy not indicated; family counseling
NM_000091:c.T4421C:p.L1474P
  • RSID: rs200302125

  • ExAC frequency: 0.003


K078 Female 28 White FSGS by biopsy, has had kidney transplantation, sibling died at age 17 y with anasarca, FHx of hematuria Autosomal recessive Alport syndrome (OMIM 203780) COL4A4 NM_000092:c.G4288A:p.G1430R
  • RSID: NA

  • ExAC frequency: 2.3 × 10−3

Compound heterozygosity confirmed by testing allele transmission in offspring; immunosuppressive therapy not indicated; family counseling; patient opted to pursue pregnancy after genetic diagnosis clarified recessive inheritance
NM_000092:c.213_239del:p.P72_G80delPQGPIGPLG
  • RSID: NA

  • ExAC frequency: 2.3 × 10−3


K058 Male 28 White FSGS by biopsy, undergoing kidney transplant evaluation positive FHx for nephropathy Autosomal dominant Alport syndrome (OMIM 104200) COL4A4 NM_000092:c.G1145C:p.G382A Immunosuppressive therapy not indicated; family screening for donor evaluation; referred for gene therapy trial
RSID: rs751952236
ExAC frequency: 4 × 10−5

K028 Female 57 White mild CKD of unknown cause with hematuria. TBMD diagnosed as a child (self-reported), X-linked Alport syndrome (OMIM 301050) COL4A5 NM_000495:c.G5030A:p.R1677Q Auditory and ophthalmology screening; referred for clinical trial (NCT02855268)
RSID: rs104886308
ExAC frequency: 2.3 × 10−5

K064 Male 48 White CKD of unknown cause with congenital small left kidney, diabetes, no prior kidney biopsy. HNF1B-associated disease (OMIM 137920) HNF1B NM_000458:c.C742T:p.Q248X Insulin therapy; screening for hyperuricemia, hypomagnesemia, and hypoparathyroidism; family screening and counseling
RSID: NA
ExAC frequency: 0

K065 Male 20 White Presented with hypertension and hypokalemia at age 13 y Liddle syndrome (OMIM 177200) SCNN1G NM_001039:c.C1874G:p.P625R Treat with amiloride
RSID: NA
ExAC frequency: 0

K027 Female 44 White Gitelman syndrome, type 2 diabetes Gitelman syndrome (OMIM 263800) SLC12A3 NM_000339: A2899G:p.R967G
  • RSID: NA

  • ExAC frequency: 0

NM_000339:c.2986_2987insGCTC:p.Y999Afs*50
  • RSID: NA

  • ExAC frequency: 0


K006 Female 42 White Biopsy-proven FSGS, mother with ESRD has undergone kidney transplantation FSGS type 2(OMIM 603965) TRPC6 TRPC6:NM_004621: A434G:p.H145R Affected mother tested positive for mutation; immunosuppression is not indicated
RSID: NA
ExAC frequency: 0

K007 Male 55 White CKD with chronic tubulointerstitial nephropathy on biopsy, undergoing kidney transplant evaluation, Strong FHx for dominant transmission of CKD/ESRD Autosomal dominant medullary cystic kidney disease type 2(OMIM 603860) UMOD NM_001008389:c.G317A:p.C106F Family screening and counseling; monitor uric acid levels
RSID: rs398123697
ExAC frequency: 3.7 × 10−5

K016 Male 21 White/Hispanic Gout and CKD of unknown cause, no biopsy; positive FHx for dominant transmission of ESRD/gout Autosomal dominant medullary cystic kidney disease type 2 (OMIM 603860) UMOD NM_001008389:c.G774C:p.W258C Family screening and counseling; monitor uric acid levels
RSID: NA
ExAC frequency: 0

K043 Female 45 Asian CKD with chronic tubulointerstitial nephropathy by biopsy, positive FHx for dominant transmission of CKD and gout Autosomal dominant medullary cystic kidney disease type 2 (OMIM 603860) UMOD NM_001008389:c.T638A:p.M213K Family screening and counseling; monitor uric acid levels
RSID: NA
ExAC frequency: 0

CHARGE = coloboma, heart defects, atresia choanae, growth retardation, genital abnormalities, and ear abnormalities; CKD = chronic kidney disease; ESRD = end-stage renal disease; ExAC = Exome Aggregation Consortium; FHx = family history; FSGS = focal segmental glomerulosclerosis; NA = not applicable ; OMIM = Online Mendelian Inheritance in Man; RSID = Reference Single Nucleotide Polymorphism identification number ; TBMD = thin basement membrane disease.

Likely a pathogenic mutation.

Also known as renal cysts and diabetes syndrome or maturity-onset diabetes of the young type 5.